GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $11,245,000 | +48.1% | 384,168 | +28.9% | 0.08% | +47.1% |
Q3 2021 | $7,594,000 | +73.3% | 298,051 | +138.3% | 0.05% | +70.0% |
Q2 2021 | $4,381,000 | -18.9% | 125,095 | -5.6% | 0.03% | -28.6% |
Q1 2021 | $5,401,000 | -24.2% | 132,540 | -19.4% | 0.04% | -32.3% |
Q4 2020 | $7,125,000 | +1259.7% | 164,520 | +1630.5% | 0.06% | +1140.0% |
Q3 2020 | $524,000 | +16.7% | 9,507 | -66.4% | 0.01% | -50.0% |
Q1 2016 | $449,000 | – | 28,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |